Associations between adipokines and obesity-related cancer

Frontiers in Bioscience

Volumn 16, Issue 5, 2011, Pages 1634-1650

  Paz Filho, Gilberto ^a   Lim, Ee Lyn ^b   Wong, Ma Li ^a   Licinio, Julio ^a  

^a Biology and Environment   (Australia)

^b TRINITY COLLEGE   (United Kingdom)

Author keywords

Adipocytokine; Adipokine; Adiponectin; Cancer; Leptin; Obesity; Review

Indexed keywords

ADIPONECTIN; LEPTIN;

BODY MASS; BREAST TUMOR; COLORECTAL TUMOR; ENDOMETRIUM TUMOR; ESOPHAGUS TUMOR; FEMALE; HUMAN; KIDNEY TUMOR; MALE; NEOPLASM; OBESITY; PANCREAS TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; REVIEW; THYROID TUMOR;

ADIPONECTIN; BODY MASS INDEX; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; ENDOMETRIAL NEOPLASMS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LEPTIN; MALE; NEOPLASMS; OBESITY; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; THYROID NEOPLASMS;

EID: 79954988230     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3810     Document Type: Article

References (167)

1. D. W. Haslam and W. P. James: Obesity. Lancet, 366(9492), 1197-209 (2005) (Pubitemid 41393598)
2. A. G. Renehan, D. L. Roberts and C. Dive: Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem, 114(1), 71-83 (2008) (Pubitemid 351998746)
3. A. G. Renehan, M. Tyson, M. Egger, R. F. Heller and M. Zwahlen: Body-mass index and incidence of cancer: a tematic review and meta-analysis of prospective observational studies. Lancet, 371(9612), 569-78 (2008) (Pubitemid 351232031)
4. E. A. Lew and L. Garfinkel: Variations in mortality by weight among 750,000 men and women. J Chronic Dis, 32(8), 563-76 (1979) (Pubitemid 9256615)
5. M. Wiseman: The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc, 67(3), 253-6 (2008)
6. G. K. Reeves, K. Pirie, V. Beral, J. Green, E. Spencer and D. Bull: Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335(7630), 1134 (2007)
7. A. Bergstrom, P. Pisani, V. Tenet, A. Wolk and H. O. Adami: Overweight as an avoidable cause of cancer in Europe. Int J Cancer, 91(3), 421-30 (2001) (Pubitemid 32049639)
8. S. C. Larsson and A. Wolk: Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr, 86(3), 556-65 (2007) (Pubitemid 47435820)
9. D. J. Harriss, G. Atkinson, K. George, N. T. Cable, T. Reilly, N. Haboubi, M. Zwahlen, M. Egger and A. G. Renehan: Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis, 11(6), 547-63 (2009)
10. A. A. Moghaddam, M. Woodward and R. Huxley: Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev, 16(12), 2533-47 (2007) (Pubitemid 351196307)
11. Z. Dai, Y. C. Xu and L. Niu: Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol, 13(31), 4199-206 (2007) (Pubitemid 47377159)
12. S. C. Larsson and A. Wolk: Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer, 96(9), 1457-61 (2007) (Pubitemid 46685777)
13. S. C. Larsson and A. Wolk: Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer, 97(7), 1005-8 (2007) (Pubitemid 47519294)
14. D. Saunders, D. Seidel, M. Allison and G. Lyratzopoulos: Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Aliment Pharmacol Ther, 31(10), 1051-63
15. A. Mathew, P. S. George and G. Ildaphonse: Obesity and kidney cancer risk in women: a meta-analysis (1992-2008). Asian Pac J Cancer Prev, 10(3), 471-8 (2009)
16. G. Ildaphonse, P. S. George and A. Mathew: Obesity and kidney cancer risk in men: a meta-analysis (1992-2008). Asian Pac J Cancer Prev, 10(2), 279-86 (2009)
17. S. C. Larsson, N. Orsini and A. Wolk: Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int J Cancer, 120(9), 1993-8 (2007) (Pubitemid 46418379)
18. A. A. Arslan, K. J. Helzlsouer, C. Kooperberg, X. O. Shu, E. Steplowski, H. B. Bueno-de-Mesquita, C. S. Fuchs, M. D. Gross, E. J. Jacobs, A. Z. Lacroix, G. M. Petersen, R. Z. Stolzenberg-Solomon, W. Zheng, D. Albanes, L. Amundadottir, W. R. Bamlet, A. Barricarte, S. A. Bingham, H. Boeing, M. C. Boutron-Ruault, J. E. Buring, S. J. Chanock, S. Clipp, J. M. Gaziano, E. L. Giovannucci, S. E. Hankinson, P. Hartge, R. N. Hoover, D. J. Hunter, A. Hutchinson, K. B. Jacobs, P. Kraft, S. M. Lynch, J. Manjer, J. E. Manson, A. McTiernan, R. R. McWilliams, J. B. Mendelsohn, D. S. Michaud, D. Palli, T. E. Rohan, N. Slimani, G. Thomas, A. Tjonneland, G. S. Tobias, D. Trichopoulos, J. Virtamo, B. M. Wolpin, K. Yu, A. Zeleniuch-Jacquotte and A. V. Patel: Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med, 170(9), 791-802 (2010)
19. C. M. Olsen, A. C. Green, D. C. Whiteman, S. Sadeghi, F. Kolahdooz and P. M. Webb: Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer, 43(4), 690-709 (2007) (Pubitemid 46502901)
20. D. M. Purdie, C. J. Bain, P. M. Webb, D. C. Whiteman, S. Pirozzo and A. C. Green: Body size and ovarian cancer: casecontrol study and systematic review (Australia). Cancer Causes Control, 12(9), 855-63 (2001) (Pubitemid 33010624)
21. R. Suzuki, N. Orsini, S. Saji, T. J. Key and A. Wolk: Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis. Int J Cancer, 124(3), 698-712 (2009)
22. R. J. MacInnis and D. R. English: Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control, 17(8), 989-1003 (2006) (Pubitemid 44290764)
23. S. C. Larsson and A. Wolk: Body mass index and risk of multiple myeloma: a meta-analysis. Int J Cancer, 121(11), 2512-6 (2007) (Pubitemid 350022422)
24. S. C. Larsson and A. Wolk: Obesity and risk of non- Hodgkin's lymphoma: a meta-analysis. Int J Cancer, 121(7), 1564-70 (2007) (Pubitemid 47328717)
25. A. Steffen, M. B. Schulze, T. Pischon, T. Dietrich, E. Molina, M. D. Chirlaque, A. Barricarte, P. Amiano, J. R. Quiros, R. Tumino, A. Mattiello, D. Palli, P. Vineis, C. Agnoli, G. Misirli, P. Boffetta, R. Kaaks, S. Rohrmann, H. B. Buenode- Mesquita, P. H. Peeters, A. M. May, E. A. Spencer, N. E. Allen, S. Bingham, A. Tjonneland, J. Halkjaer, K. Overvad, J. Stegger, J. Manjer, B. Lindkvist, G. Hallmanns, R. Stenling, E. Lund, E. Riboli, C. A. Gonzalez and H. Boeing: Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev, 18(7), 2079-89 (2009)
26. D. P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham and A. H. Anis: The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health, 9, 88 (2009)
27. J. S. Flier: Obesity wars: molecular progress confronts an expanding epidemic. Cell, 116(2), 337-50 (2004) (Pubitemid 38167322)
28. R. S. Ahima: Adipose tissue as an endocrine organ. Obesity (Silver Spring), 14 Suppl 5, 242S-249S (2006)
29. O. A. MacDougald and C. F. Burant: The rapidly expanding family of adipokines. Cell Metab, 6(3), 159-61 (2007) (Pubitemid 47324145)
30. C. Garofalo and E. Surmacz: Leptin and cancer. J Cell Physiol, 207(1), 12-22 (2006)
31. T. Kelesidis, I. Kelesidis, S. Chou and C. S. Mantzoros: Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med, 152(2), 93-100 (2010)
32. C. L. Boguszewski, G. Paz-Filho and L. A. Velloso: Neuroendocrine body weight regulation: integration between fat tissue, gastrointestinal tract, and the brain. Endokrynol Pol, 61(2), 194-206 (2010)
33. G. Fruhbeck: Intracellular signalling pathways activated by leptin. Biochem J, 393(Pt 1), 7-20 (2006) (Pubitemid 43049298)
34. K. Baicy, E. D. London, J. Monterosso, M. L. Wong, T. Delibasi, A. Sharma and J. Licinio: Leptin replacement alters brain response to food cues in genetically leptindeficient adults. Proc Natl Acad Sci U S A, 104(46), 18276-9 (2007) (Pubitemid 350210857)
35. I. S. Farooqi, G. Matarese, G. M. Lord, J. M. Keogh, E. Lawrence, C. Agwu, V. Sanna, S. A. Jebb, F. Perna, S. Fontana, R. I. Lechler, A. M. DePaoli and S. O'Rahilly: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest, 110(8), 1093-103 (2002) (Pubitemid 35215890)
36. J. Licinio, S. Caglayan, M. Ozata, B. O. Yildiz, P. B. de Miranda, F. O'Kirwan, R. Whitby, L. Liang, P. Cohen, S. Bhasin, R. M. Krauss, J. D. Veldhuis, A. J. Wagner, A. M. DePaoli, S. M. McCann and M. L. Wong: Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A, 101(13), 4531-6 (2004) (Pubitemid 38437445)
37. J. A. Matochik, E. D. London, B. O. Yildiz, M. Ozata, S. Caglayan, A. M. DePaoli, M. L. Wong and J. Licinio: Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J Clin Endocrinol Metab, 90(5), 2851-4 (2005) (Pubitemid 40686335)
38. G. Paz-Filho, K. Esposito, B. Hurwitz, A. Sharma, C. Dong, V. Andreev, T. Delibasi, H. Erol, A. Ayala, M. L. Wong and J. Licinio: Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients. Am J Physiol Endocrinol Metab, 295(6), E1401-8 (2008)
39. G. J. Paz-Filho, T. Babikian, R. Asarnow, T. Delibasi, K. Esposito, H. K. Erol, M. L. Wong and J. Licinio: Leptin replacement improves cognitive development. PLoS One, 3(8), e3098 (2008)
40. G. J. Paz-Filho, A. Ayala, K. Esposito, H. K. Erol, T. Delibasi, B. E. Hurwitz, M. L. Wong and J. Licinio: Effects of leptin on lipid metabolism. Horm Metab Res, 40(8), 572-4 (2008)
41. A. Bouloumie, H. C. Drexler, M. Lafontan and R. Busse: Leptin, the product of Ob gene, promotes angiogenesis. Circ Res, 83(10), 1059-66 (1998) (Pubitemid 28520935)
42. P. Trayhurn and I. S. Wood: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr, 92(3), 347-55 (2004) (Pubitemid 40277057)
43. M. R. Sierra-Honigmann, A. K. Nath, C. Murakami, G. Garcia-Cardena, A. Papapetropoulos, W. C. Sessa, L. A. Madge, J. S. Schechner, M. B. Schwabb, P. J. Polverini and J. R. Flores-Riveros: Biological action of leptin as an angiogenic factor. Science, 281(5383), 1683-6 (1998) (Pubitemid 28435586)
44. G. Boden and G. I. Shulman: Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest, 32 Suppl 3, 14-23 (2002) (Pubitemid 41704996)
45. A. W. Hsing, L. C. Sakoda and S. Chua, Jr.: Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr, 86(3), s843-57 (2007)
46. H. Li, M. J. Stampfer, L. Mucci, N. Rifai, W. Qiu, T. Kurth and J. Ma: A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem, 56(1), 34-43 (2010)
47. R. Ribeiro, A. Vasconcelos, S. Costa, D. Pinto, A. Morais, J. Oliveira, F. Lobo, C. Lopes and R. Medeiros: Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate, 59(3), 268-74 (2004) (Pubitemid 38509759)
48. S. J. Freedland and E. A. Platz: Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev, 29, 88-97 (2007) (Pubitemid 47229642)
49. K. A. Frankenberry, P. Somasundar, D. W. McFadden and L. C. Vona-Davis: Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg, 188(5), 560-5 (2004) (Pubitemid 39491105)
50. P. Somasundar, K. A. Frankenberry, H. Skinner, G. Vedula, D. W. McFadden, D. Riggs, B. Jackson, R. Vangilder, S. M. Hileman and L. C. Vona-Davis: Prostate cancer cell proliferation is influenced by leptin. J Surg Res, 118(1), 71-82 (2004) (Pubitemid 38490519)
51. D. Kielar, J. S. Clark, A. Ciechanowicz, G. Kurzawski, T. Sulikowski and M. Naruszewicz: Leptin receptor isoforms expressed in human adipose tissue. Metabolism, 47(7), 844-7 (1998) (Pubitemid 28313193)
52. M. Onuma, J. D. Bub, T. L. Rummel and Y. Iwamoto: Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem, 278(43), 42660-7 (2003) (Pubitemid 37310540)
53. P. Somasundar, A. K. Yu, L. Vona-Davis and D. W. McFadden: Differential effects of leptin on cancer in vitro. J Surg Res, 113(1), 50-5 (2003) (Pubitemid 36999792)
54. H. Y. Park, H. M. Kwon, H. J. Lim, B. K. Hong, J. Y. Lee, B. E. Park, Y. Jang, S. Y. Cho and H. S. Kim: Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med, 33(2), 95-102 (2001) (Pubitemid 32655888)
55. L. Vona-Davis and D. P. Rose: Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer, 14(2), 189-206 (2007) (Pubitemid 47242622)
56. A. Maccio, C. Madeddu, G. Gramignano, C. Mulas, C. Floris, D. Massa, G. Astara, P. Chessa and G. Mantovani: Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications. J Mol Med, 88(7), 677-86 (2010)
57. D. P. Rose, D. Komninou and G. D. Stephenson: Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev, 5(3), 153-65 (2004) (Pubitemid 38998240)
58. D. Cirillo, A. M. Rachiglio, R. la Montagna, A. Giordano and N. Normanno: Leptin signaling in breast cancer: an overview. J Cell Biochem, 105(4), 956-64 (2008)
59. K. A. Brown and E. R. Simpson: Obesity and breast cancer: progress to understanding the relationship. Cancer Res, 70(1), 4-7 (2010)
60. M. Castellucci, R. De Matteis, A. Meisser, R. Cancello, V. Monsurro, D. Islami, R. Sarzani, D. Marzioni, S. Cinti and P. Bischof: Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod, 6(10), 951-8 (2000)
61. C. Garofalo, M. Koda, S. Cascio, M. Sulkowska, L. Kanczuga-Koda, J. Golaszewska, A. Russo, S. Sulkowski and E. Surmacz: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res, 12(5), 1447-53 (2006)
62. M. Terrasi, E. Fiorio, A. Mercanti, M. Koda, C. A. Moncada, S. Sulkowski, S. Merali, A. Russo and E. Surmacz: Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells. Int J Cancer, 125(5), 1038-44 (2009)
63. F. Revillion, M. Charlier, V. Lhotellier, L. Hornez, S. Giard, M. C. Baranzelli, J. Djiane and J. P. Peyrat: Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res, 12(7 Pt 1), 2088-94 (2006)
64. M. P. Cleary, F. C. Phillips, S. C. Getzin, T. L. Jacobson, M. K. Jacobson, T. A. Christensen, S. C. Juneja, J. P. Grande and N. J. Maihle: Genetically obese MMTVTGF- alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat, 77(3), 205-15 (2003) (Pubitemid 36197635)
65. M. P. Cleary, S. C. Juneja, F. C. Phillips, X. Hu, J. P. Grande and N. J. Maihle: Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med (Maywood), 229(2), 182-93 (2004) (Pubitemid 38146562)
66. P. Stattin, A. Lukanova, C. Biessy, S. Soderberg, R. Palmqvist, R. Kaaks, T. Olsson and E. Jellum: Obesity and colon cancer: does leptin provide a link? Int J Cancer, 109(1), 149-52 (2004) (Pubitemid 38160676)
67. P. Stattin, R. Palmqvist, S. Soderberg, C. Biessy, B. Ardnor, G. Hallmans, R. Kaaks and T. Olsson: Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep, 10(6), 2015-21 (2003)
68. K. Tamakoshi, H. Toyoshima, K. Wakai, M. Kojima, K. Suzuki, Y. Watanabe, N. Hayakawa, H. Yatsuya, T. Kondo, S. Tokudome, S. Hashimoto, S. Suzuki, M. Kawado, K. Ozasa, Y. Ito and A. Tamakoshi: Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncology, 68(4-6), 454-61 (2005) (Pubitemid 41160977)
69. T. E. Nakajima, Y. Yamada, T. Hamano, K. Furuta, T. Matsuda, S. Fujita, K. Kato, T. Hamaguchi and Y. Shimada: Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci, 101(5), 1286-91 (2010)
70. L. Tessitore, B. Vizio, O. Jenkins, I. De Stefano, C. Ritossa, J. M. Argiles, C. Benedetto and A. Mussa: Leptin expression in colorectal and breast cancer patients. Int J Mol Med, 5(4), 421-6 (2000)
71. A. Kumor, P. Daniel, M. Pietruczuk and E. Malecka- Panas: Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis, 24(3), 275-81 (2009)
72. F. F. Bolukbas, H. Kilic, C. Bolukbas, M. Gumus, M. Horoz, N. S. Turhal and B. Kavakli: Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer, 4, 29 (2004)
73. M. Koda, M. Sulkowska, L. Kanczuga-Koda, S. Cascio, G. Colucci, A. Russo, E. Surmacz and S. Sulkowski: Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer. Ann Oncol, 18 Suppl 6, vi116-9 (2007)
74. S. S. Paik, S. M. Jang, K. S. Jang, K. H. Lee, D. Choi and S. J. Jang: Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Ann Surg Oncol, 16(2), 297-303 (2009)
75. S. Attoub, V. Noe, L. Pirola, E. Bruyneel, E. Chastre, M. Mareel, M. P. Wymann and C. Gespach: Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and racdependent signaling pathways. FASEB J, 14(14), 2329-38 (2000)
76. M. Koda, M. Sulkowska, L. Kanczuga-Koda, E. Surmacz and S. Sulkowski: Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol, 60(8), 902-6 (2007) (Pubitemid 47234437)
77. J. C. Hardwick, G. R. Van Den Brink, G. J. Offerhaus, S. J. Van Deventer and M. P. Peppelenbosch: Leptin is a growth factor for colonic epithelial cells. Gastroenterology, 121(1), 79-90 (2001) (Pubitemid 32591517)
78. S. Uddin, P. P. Bavi, A. R. Hussain, G. Alsbeih, N. Al- Sanea, A. Abduljabbar, L. H. Ashari, S. Alhomoud, F. Al- Dayel, M. Ahmed and K. S. Al-Kuraya: Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis, 30(11), 1832-40 (2009)
79. O. O. Ogunwobi and I. L. Beales: The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis, 22(4), 401-9 (2007) (Pubitemid 46336244)
80. J. I. Fenton, N. G. Hord, J. A. Lavigne, S. N. Perkins and S. D. Hursting: Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines. Cancer Epidemiol Biomarkers Prev, 14(7), 1646-52 (2005) (Pubitemid 40995074)
81. T. Aparicio, L. Kotelevets, A. Tsocas, J. P. Laigneau, I. Sobhani, E. Chastre and T. Lehy: Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut, 54(8), 1136-45 (2005) (Pubitemid 41025909)
82. K. N. Ealey, S. Lu and M. C. Archer: Development of aberrant crypt foci in the colons of ob/ob and db/db mice: evidence that leptin is not a promoter. Mol Carcinog, 47(9), 667-77 (2008)
83. Z. Liu, T. Uesaka, H. Watanabe and N. Kato: High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol, 19(5), 1009-14 (2001)
84. A. Engeland, S. Tretli, L. A. Akslen and T. Bjorge: Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer, 95(3), 366-70 (2006) (Pubitemid 44187599)
85. F. Clavel-Chapelon, G. Guillas, L. Tondeur, C. Kernaleguen and M. C. Boutron-Ruault: Risk of differentiated thyroid cancer in relation to adult weight, height and body shape over life: the French E3N cohort. Int J Cancer, 126(12), 2984-90 (2010)
86. M. F. Leitzmann, A. Brenner, S. C. Moore, C. Koebnick, Y. Park, A. Hollenbeck, A. Schatzkin and E. Ron: Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer, 126(12), 2947-56 (2010)
87. M. Akinci, F. Kosova, B. Cetin, S. Aslan, Z. Ari and A. Cetin: Leptin levels in thyroid cancer. Asian J Surg, 32(4), 216-23 (2009)
88. K. W. Nowak, P. Kaczmarek, P. Mackowiak, A. Ziolkowska, G. Albertin, W. J. Ginda, M. Trejter, G. G. Nussdorfer and L. K. Malendowicz: Rat thyroid gland expresses the long form of leptin receptors, and leptin stimulates the function of the gland in euthyroid non-fasted animals. Int J Mol Med, 9(1), 31-4 (2002)
89. S. P. Cheng, C. W. Chi, C. Y. Tzen, T. L. Yang, J. J. Lee, T. P. Liu and C. L. Liu: Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery, 147(6), 847-53 (2010)
90. S. Uddin, P. Bavi, A. K. Siraj, M. Ahmed, M. Al- Rasheed, A. R. Hussain, T. Amin, A. Alzahrani, F. Al- Dayel, J. Abubaker, R. Bu and K. S. Al-Kuraya: Leptin-R and its association with PI3K/Akt signaling pathway in papillary thyroid carcinoma. Endocr Relat Cancer, 17(1), 191-202 (2010)
91. S. P. Cheng, P. H. Yin, Y. C. Chang, C. H. Lee, S. Y. Huang and C. W. Chi: Differential roles of leptin in regulating cell migration in thyroid cancer cells. Oncol Rep, 23(6), 1721-7 (2010)
92. T. N. Spyridopoulos, E. T. Petridou, N. Dessypris, A. Terzidis, A. Skalkidou, C. Deliveliotis and G. P. Chrousos: Inverse association of leptin levels with renal cell carcinoma: results from a case-control study. Hormones (Athens), 8(1), 39-46 (2009)
93. A. Horiguchi, M. Sumitomo, J. Asakuma, T. Asano, R. Zheng, D. M. Nanus and M. Hayakawa: Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol, 176(4 Pt 1), 1631-5 (2006) (Pubitemid 44307222)
94. A. Horiguchi, M. Sumitomo, J. Asakuma, T. Asano, R. Zheng, D. M. Nanus and M. Hayakawa: Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway. J Urol, 176(4 Pt 1), 1636-41 (2006) (Pubitemid 44316854)
95. L. Li, Y. Gao, L. L. Zhang and D. L. He: Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells. Cancer Biol Ther, 7(11), 1787-92 (2008)
96. H. A. Drabkin and R. M. Gemmill: Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC). Adv Cancer Res, 107, 39-56 (2010)
97. E. Petridou, M. Belechri, N. Dessypris, P. Koukoulomatis, E. Diakomanolis, E. Spanos and D. Trichopoulos: Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab, 46(3-4), 147-51 (2002) (Pubitemid 34920698)
98. S. S. Yuan, K. B. Tsai, Y. F. Chung, T. F. Chan, Y. T. Yeh, L. Y. Tsai and J. H. Su: Aberrant expression and possible involvement of the leptin receptor in endometrial cancer. Gynecol Oncol, 92(3), 769-75 (2004)
99. A. Cymbaluk, A. Chudecka-Glaz and I. Rzepka- Gorska: Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol, 136(1), 74-7 (2008)
100. H. Koshiba, J. Kitawaki, H. Ishihara, N. Kado, I.Kusuki, K. Tsukamoto and H. Honjo: Progesterone inhibition of functional leptin receptor mRNA expression in human endometrium. Mol Hum Reprod, 7(6), 567-72 (2001) (Pubitemid 32536876)
101. M. Koda, M. Sulkowska, A. Wincewicz, L. Kanczuga- Koda, B. Musiatowicz, M. Szymanska and S. Sulkowski: Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann N Y Acad Sci, 1095, 90-8 (2007) (Pubitemid 47092441)
102. M. Bogusiewicz, A. Semczuk, M. Gogacz, D. Skomra, J. A. Jakowicki and T. Rechberger: Lack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas. Cancer Lett, 238(1), 61-8 (2006) (Pubitemid 43851145)
103. D. Sharma, N. K. Saxena, P. M. Vertino and F. A. Anania: Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer, 13(2), 629-40 (2006) (Pubitemid 43886682)
104. S. Catalano, C. Giordano, P. Rizza, G. Gu, I. Barone, D. Bonofiglio, F. Giordano, R. Malivindi, D. Gaccione, M. Lanzino, F. De Amicis and S. Ando: Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation. J Cell Physiol, 218(3), 490-500 (2009)
105. C. Carino, A. B. Olawaiye, S. Cherfils, T. Serikawa, M. P. Lynch, B. R. Rueda and R. R. Gonzalez: Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells. Int J Cancer, 123(12), 2782-90 (2008)
106. R. Pezzilli, A. Barassi, M. M. Corsi, A. M. Morselli- Labate, D. Campana, R. Casadei, D. Santini, R. Corinaldesi and G. M. D'Eril: Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms. Scand J Gastroenterol, 45(1), 93-9 (2010)
107. M. Dalamaga, K. Karmaniolas, A. Panagiotou, A. Hsi, J. Chamberland, C. Dimas, A. Lekka and C. S. Mantzoros: Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a casecontrol study. Cancer Causes Control, 20(2), 193-9 (2009)
108. D. R. Brown, D. E. Berkowitz and M. J. Breslow: Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer. J Clin Endocrinol Metab, 86(1), 162-6 (2001) (Pubitemid 32109791)
109. R. Z. Stolzenberg-Solomon, B. I. Graubard, S. Chari, P. Limburg, P. R. Taylor, J. Virtamo and D. Albanes: Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA, 294(22), 2872-8 (2005) (Pubitemid 41785868)
110. N. J. Zyromski, A. Mathur, H. A. Pitt, T. E. Wade, S. Wang, P. Nakshatri, D. A. Swartz-Basile and H. Nakshatri: Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery, 146(2), 258-63 (2009)
111. T. E. Nakajima, Y. Yamada, T. Hamano, K. Furuta, I. Oda, H. Kato, K. Kato, T. Hamaguchi and Y. Shimada: Adipocytokines and squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol, 136(2), 261-6 (2010)
112. B. J. Kendall, G. A. Macdonald, N. K. Hayward, J. B. Prins, I. Brown, N. Walker, N. Pandeya, A. C. Green, P. M. Webb and D. C. Whiteman: Leptin and the risk of Barrett's oesophagus. Gut, 57(4), 448-54 (2008) (Pubitemid 351442525)
113. D. Diakowska, M. Krzystek-Korpacka, K. Markocka- Maczka, W. Diakowski, M. Matusiewicz and K. Grabowski: Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexiaanorexia syndrome (CAS) and non-malignant CAS of the alimentary tract. Cytokine, 51(2), 132-7 (2010)
114. J. M. Howard, P. Beddy, D. Ennis, M. Keogan, G. P. Pidgeon and J. V. Reynolds: Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg, 97(7), 1020-7 (2010)
115. O. O. Ogunwobi and I. L. Beales: Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and TGF-alpha mediated transactivation of the epidermal growth factor receptor. Br J Biomed Sci, 65(3), 121-7 (2008)
116. O. O. Ogunwobi and I. L. Beales: Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol, 285(1-2), 43-50 (2008)
117. I. L. Beales and O. O. Ogunwobi: Leptin synergistically enhances the anti-apoptotic and growthpromoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture. Mol Cell Endocrinol, 274(1-2), 60-8 (2007) (Pubitemid 47126685)
118. O. Ogunwobi, G. Mutungi and I. L. Beales: Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2- dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2- terminal kinase activation. Endocrinology, 147(9), 4505-16 (2006) (Pubitemid 44268402)
119. P. Somasundar, D. Riggs, B. Jackson, L. Vona-Davis and D. W. McFadden: Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Am J Surg, 186(5), 575-8 (2003) (Pubitemid 37352849)
120. S. E. Wozniak, L. L. Gee, M. S. Wachtel and E. E. Frezza: Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci, 54(9), 1847-56 (2009)
121. M. Liu and F. Liu: Transcriptional and posttranslational regulation of adiponectin. Biochem J, 425(1), 41-52
122. T. Kadowaki and T. Yamauchi: Adiponectin and adiponectin receptors. Endocr Rev, 26(3), 439-51 (2005) (Pubitemid 40686653)
123. N. Ouchi, S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama, K. Hotta, M. Nishida, M. Takahashi, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Funahashi and Y. Matsuzawa: Adiponectin, an adipocytederived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation, 102(11), 1296-301 (2000)
124. E. Brakenhielm, N. Veitonmaki, R. Cao, S. Kihara, Y. Matsuzawa, B. Zhivotovsky, T. Funahashi and Y. Cao: Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A, 101(8), 2476-81 (2004) (Pubitemid 38269336)
125. I. Kelesidis, T. Kelesidis and C. S. Mantzoros: Adiponectin and cancer: a systematic review. Br J Cancer, 94(9), 1221-5 (2006)
126. S. Goktas, M. I. Yilmaz, K. Caglar, A. Sonmez, S. Kilic and S. Bedir: Prostate cancer and adiponectin. Urology, 65(6), 1168-72 (2005) (Pubitemid 40824911)
127. J. D. Bub, T. Miyazaki and Y. Iwamoto: Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun, 340(4), 1158-66 (2006) (Pubitemid 43083400)
128. C. Mantzoros, E. Petridou, N. Dessypris, C. Chavelas, M. Dalamaga, D. M. Alexe, Y. Papadiamantis, C. Markopoulos, E. Spanos, G. Chrousos and D. Trichopoulos: Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89(3), 1102-7 (2004) (Pubitemid 38368397)
129. M. P. Cleary and M. E. Grossmann: Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology, 150(6), 2537-42 (2009)
130. K. Y. Kim, A. Baek, J. E. Hwang, Y. A. Choi, J. Jeong, M. S. Lee, D. H. Cho, J. S. Lim, K. I. Kim and Y. Yang: Adiponectin-activated AMPK stimulates dephosphorylation of Akt through protein phosphatase 2A activation. Cancer Res, 69(9), 4018-26 (2009)
131. A. M. Lorincz and S. Sukumar: Molecular links between obesity and breast cancer. Endocr Relat Cancer, 13(2), 279-92 (2006) (Pubitemid 43886659)
132. A. Lukanova, S. Soderberg, R. Kaaks, E. Jellum and P. Stattin: Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 15(2), 401-2 (2006) (Pubitemid 43342195)
133. E. K. Wei, E. Giovannucci, C. S. Fuchs, W. C. Willett and C. S. Mantzoros: Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst, 97(22), 1688-94 (2005) (Pubitemid 41672235)
134. S. Otake, H. Takeda, Y. Suzuki, T. Fukui, S. Watanabe, K. Ishihama, T. Saito, H. Togashi, T. Nakamura, Y. Matsuzawa and S. Kawata: Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res, 11(10), 3642-6 (2005) (Pubitemid 40685579)
135. T. Yamaji, M. Iwasaki, S. Sasazuki and S. Tsugane: Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res, 70(13), 5430-7 (2010)
136. D. Barb, C. J. Williams, A. K. Neuwirth and C. S. Mantzoros: Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr, 86(3), s858-66 (2007)
137. M. Sugiyama, H. Takahashi, K. Hosono, H. Endo, S. Kato, K. Yoneda, Y. Nozaki, K. Fujita, M. Yoneda, K. Wada, H. Nakagama and A. Nakajima: Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol, 34(2), 339-44 (2009)
138. A. Y. Kim, Y. S. Lee, K. H. Kim, J. H. Lee, H. K. Lee, S. H. Jang, S. E. Kim, G. Y. Lee, J. W. Lee, S. A. Jung, H. Y. Chung, S. Jeong and J. B. Kim: Adiponectin represses colon cancer cell proliferation via AdipoR1- and - R2-mediated AMPK activation. Mol Endocrinol, 24(7), 1441-52 (2010)
139. J. I. Fenton, J. M. Birmingham, S. D. Hursting and N. G. Hord: Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int J Cancer, 122(11), 2437-45 (2008) (Pubitemid 351590475)
140. J. T. Park, T. H. Yoo, T. I. Chang, D. H. Lee, J. H. Lee, J. E. Lee, H. Y. Choi, S. W. Kang, D. S. Han and D. R. Ryu: Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients. Metabolism (2010)
141. J. H. Pinthus, N. Kleinmann, B. Tisdale, S. Chatterjee, J. P. Lu, A. Gillis, T. Hamlet, G. Singh, F. Farrokhyar and A. Kapoor: Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol, 54(4), 866-73 (2008)
142. T. N. Spyridopoulos, E. T. Petridou, A. Skalkidou, N. Dessypris, G. P. Chrousos and C. S. Mantzoros: Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer, 120(7), 1573-8 (2007) (Pubitemid 46355396)
143. A. Horiguchi, K. Ito, M. Sumitomo, F. Kimura, T. Asano and M. Hayakawa: Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol, 38(2), 106-11 (2008) (Pubitemid 351337954)
144. P. T. Soliman, D. Wu, G. Tortolero-Luna, K. M. Schmeler, B. M. Slomovitz, M. S. Bray, D. M. Gershenson and K. H. Lu: Association between adiponectin, insulin resistance, and endometrial cancer. Cancer, 106(11), 2376-81 (2006) (Pubitemid 43787661)
145. A. E. Cust, R. Kaaks, C. Friedenreich, F. Bonnet, M. Laville, A. Lukanova, S. Rinaldi, L. Dossus, N. Slimani, E. Lundin, A. Tjonneland, A. Olsen, K. Overvad, F. Clavel- Chapelon, S. Mesrine, V. Joulin, J. Linseisen, S. Rohrmann, T. Pischon, H. Boeing, D. Trichopoulos, A. Trichopoulou, V. Benetou, D. Palli, F. Berrino, R. Tumino, C. Sacerdote, A. Mattiello, J. R. Quiros, M. A. Mendez, M. J. Sanchez, N. Larranaga, M. J. Tormo, E. Ardanaz, H. B. Bueno-de-Mesquita, P. H. Peeters, C. H. van Gils, K. T. Khaw, S. Bingham, N. Allen, T. Key, M. Jenab and E. Riboli: Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab, 92(1), 255-63 (2007) (Pubitemid 46067541)
146. L. Dal Maso, L. S. Augustin, A. Karalis, R. Talamini, S. Franceschi, D. Trichopoulos, C. S. Mantzoros and C. La Vecchia: Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab, 89(3), 1160-3 (2004) (Pubitemid 38368405)
147. Y. Takemura, Y. Osuga, T. Yamauchi, M. Kobayashi, M. Harada, T. Hirata, C. Morimoto, Y. Hirota, O. Yoshino, K. Koga, T. Yano, T. Kadowaki and Y. Taketani: Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology, 147(7), 3203-10 (2006) (Pubitemid 43901111)
148. L. Cong, J. Gasser, J. Zhao, B. Yang, F. Li and A. Z. Zhao: Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr Relat Cancer, 14(3), 713-20 (2007) (Pubitemid 350074060)
149. M. C. Chang, Y. T. Chang, T. C. Su, W. S. Yang, C. L. Chen, Y. W. Tien, P. C. Liang, S. C. Wei and J. M. Wong: Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis. Pancreas, 35(1), 16-21 (2007)
150. M. Dalamaga, I. Migdalis, J. L. Fargnoli, E. Papadavid, E. Bloom, N. Mitsiades, K. Karmaniolas, N. Pelecanos, S. Tseleni-Balafouta, A. Dionyssiou-Asteriou and C. S. Mantzoros: Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control, 20(5), 625-33 (2009)
151. R. Z. Stolzenberg-Solomon, S. Weinstein, M. Pollak, Y. Tao, P. R. Taylor, J. Virtamo and D. Albanes: Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol, 168(9), 1047-55 (2008)
152. I. Wolf, S. Sadetzki, H. Kanety, Y. Kundel, C. Pariente, N. Epstein, B. Oberman, R. Catane, B. Kaufman and I. Shimon: Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer, 106(4), 966-73 (2006) (Pubitemid 43238466)
153. S. M. Brichard, M. L. Delporte and M. Lambert: Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res, 35(6), 337-42 (2003) (Pubitemid 37102677)
154. G. Garcea, A. R. Dennison, W. P. Steward and D. P. Berry: Role of inflammation in pancreatic carcinogenesis and the implications for future therapy. Pancreatology, 5(6), 514-29 (2005) (Pubitemid 41407282)
155. J. Chen and X. F. Huang: Interleukin-6 promotes carcinogenesis through multiple signal pathways. Comment on: Clinical significance of interleukin-6 gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig Dis Sci, 54(6), 1373-4 (2009)
156. A. Yildirim, M. Bilici, K. Cayir, V. Yanmaz, S. Yildirim and S. B. Tekin: Serum adiponectin levels in patients with esophageal cancer. Jpn J Clin Oncol, 39(2), 92-6 (2009)
157. J. H. Rubenstein, A. Dahlkemper, J. Y. Kao, M. Zhang, H. Morgenstern, L. McMahon and J. M. Inadomi: A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol, 103(6), 1358-64 (2008) (Pubitemid 351813912)
158. T. Fujita: Adiponectin and Barrett's esophagus. Am J Gastroenterol, 104(1), 243; author reply 244-5 (2009)
159. P. C. Konturek, G. Burnat, T. Rau, E. G. Hahn and S. Konturek: Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci, 53(3), 597-605 (2008) (Pubitemid 351317076)
160. M. Jaiswal, N. F. LaRusso, L. J. Burgart and G. J. Gores: Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res, 60(1), 184-90 (2000) (Pubitemid 30058750)
161. J. R. Jackson, M. P. Seed, C. H. Kircher, D. A. Willoughby and J. D. Winkler: The codependence of angiogenesis and chronic inflammation. FASEB J, 11(6), 457-65 (1997) (Pubitemid 27259987)
162. F. Balkwill and A. Mantovani: Inflammation and cancer: back to Virchow? Lancet, 357(9255), 539-45 (2001) (Pubitemid 32173595)
163. G. Lazennec and A. Richmond: Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med, 16(3), 133-44 (2010)
164. A. Mantovani, P. Allavena, A. Sica and F. Balkwill: Cancer-related inflammation. Nature, 454(7203), 436-44 (2008)
165. K. Malinowska, H. Neuwirt, I. T. Cavarretta, J. Bektic, H. Steiner, H. Dietrich, P. L. Moser, D. Fuchs, A. Hobisch and Z. Culig: Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Endocr Relat Cancer, 16(1), 155-69 (2009)
166. F. Balkwill: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol, 14(3), 171-9 (2004) (Pubitemid 38586742)
167. T. B. Dorff, B. Goldman, J. K. Pinski, P. C. Mack, P. N. Lara, Jr., P. J. Van Veldhuizen, Jr., D. I. Quinn, N. J. Vogelzang, I. M. Thompson, Jr. and M. H. Hussain: Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer. Clin Cancer Res, 16(11), 3028-34 (2010)